openPR Logo
Press release

Depression And Seasonal Affective Disorder Therapeutics Market : Drivers, Restraint & Future Growth

01-11-2019 04:42 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Future Market Insights

Depression And Seasonal Affective Disorder Therapeutics

Seasonal Affective Disorder is also referred as winter depression though it comes and goes in the winter season. The symptoms of the seasonal affective disorder often begin in autumn, when the days are getting shorter. This disorder mostly occurs in the month of December, January, and February. This disorder improves and disappears as spring and summer start. Seasonal affective disorder frequently happens due to reducing light exposure to sunlight during winter. The lack of sunlight might result improper working of the hypothalamus which may affect the production of melatonin and serotonin and also affects body’s internal clock. The symptoms of season affective disorder are persistent loss of mood, irritability, loss of pleasure in doing everyday activities, feeling lethargic and sleepy during day. The seasonal affective disorder can be treated by three methods, psychological treatment, light therapy and medication. In psychological treatment, cognitive behavioral therapy (CBT) and counseling are provided to the patient while light therapy can be done by two types: bright light treatment and dawn simulation. Medication treatment is done by prescribing the antidepressant such as SSRIs. The intake of SSRIs can lead to some side effect such as anxious, upset stomach and diarrhea.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3071

Depression and Seasonal Affective Disorder Therapeutics Market: Drivers and Restraints

The major driving factors for depression and seasonal affective disorder therapeutics market is the rise in geriatric population and change in lifestyle of people. The technological development tends to manufacture of more efficient drugs for the treatment of depression and seasonal affective disorder also responsible for the rapid of this market. The increasing awareness among the people about seasonal affective disorder will propel the growth of this market in developing countries. Favorable reimbursement scenario and more improved distribution network in developed countries will boost the growth of depression and seasonal affective disorder therapeutics market. The growing market for generic drugs and more preference of patient for light therapy will hinder the growth of depression and seasonal affective disorder therapeutics market. The patent expiry for the majority of the drugs and several side effect by consumption of anti-depressant can also restraint the growth of depression and seasonal affective disorder therapeutics market.

Depression and Seasonal Affective Disorder Therapeutics Market: Segmentation

The global depression and seasonal affective disorder therapeutics market is classified on the basis of drug type, distribution channel and geographical region.

Based on drug type, depression and seasonal affective disorder therapeutics market is segmented into following:

Selective serotonin reuptake inhibitors (SSRIs)

Norepinephrine-dopamine reuptake inhibitor (NDRI)

Serotonin and norepinephrine reuptake inhibitors (SNRIs)

Monoamine oxidase inhibitors (MAOIs)

Tricyclic antidepressants (TCAs)

Other

Based on distribution channel, depression and seasonal affective disorder therapeutics market is segmented into following:

Hospital Pharmacies

Retail Pharmacies and Drug Stores

Online Pharmacies

Depression and Seasonal Affective Disorder Therapeutics Market: Overview

Depression and seasonal affective disorder therapeutics market is expected to show substantial growth over the forecast period. According to survey published in SAGE Publication, 10 % of U.S. population suffers from the seasonal affective disorder. Depression and seasonal affective disorder therapeutics market can be classified on the basis of drug therapy and distribution channel. Based on depression and seasonal affective disorder therapeutics market is classified as selective serotonin reuptake inhibitors, norepinephrine-dopamine reuptake inhibitor, serotonin and norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, tricyclic antidepressants and other. The selective serotonin reuptake inhibitors are expected to dominate the major market in term of value over the forecast period. The major brands of SSRI’s which are dominating the on depression and seasonal affective disorder therapeutics market are Citalopram, Escitalopram, Fluoxetine, and Sertraline.

Depression and Seasonal Affective Disorder Therapeutics Market: Regional Overview

On the basis of geographical region the depression and seasonal affective disorder therapeutics market is segmented into seven key regions, viz. North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan and Middle East & Africa. North America is expected to dominate the global depression and seasonal affective disorder therapeutics market due to a large number of population suffering from the seasonal affective disorder. After North America, depression and seasonal affective disorder therapeutics market is followed by Western Europe owing to advancement in technology and development of new drugs. In APEJ region India and China is will dominate the depression and seasonal affective disorder therapeutics market due to rise in geriatric population.

To view TOC of this report is available upon request @ https://www.futuremarketinsights.com/toc/rep-gb-3071

Depression and Seasonal Affective Disorder Therapeutics Market: Key Players

Examples of some of the market participants in depression and seasonal affective disorder therapeutics market identified across the value chain include Janssen Pharmaceutical Inc., Pfizer Inc., Merck & Co., GlaxoSmithKline plc, Sanofi S.A., Eli Lilly and Company, Biogen Idec., Bristol-Myers Sqibb, Baxter Healthcare Corporation, Novartis AG, Shire plc, AstraZenecaplc.

About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Depression And Seasonal Affective Disorder Therapeutics Market : Drivers, Restraint & Future Growth here

News-ID: 1488724 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for Seasonal

Seasonal Influenza Vaccine Market 2022 | Detailed Report
The Seasonal Influenza Vaccine market study is an in-depth analysis covering several elements critical to the growth and dynamics of the market. The important facts and data provided in the Seasonal Influenza Vaccine market study for the estimated forecast period. It also, serve as a useful resource for consumers seeking guidance in making decisions to strengthen their current market position or enter the industry. The global Seasonal Influenza Vaccine market
Trending 2020: Seasonal Candy Market Booming Worldwide
Exclusive Research report on Seasonal Candy market 2020 with industry primary research, secondary research, product research, size, trends and forecast by 2030. This research report based on 'Seasonal Candy market' and available with Market Study Report includes latest and upcoming industry trends in addition to the global spectrum of the 'Seasonal Candy market' that includes numerous regions. Likewise, the report also expands on intricate details pertaining to contributions by key players,
05-19-2017 | Health & Medicine
Envolve
Tips to Triumph over Seasonal Allergies
Allergy season has arrived and brought with it a haze of pollen and allergens, leaving millions of affected individuals longing for relief. The health experts at Envolve, an integrated healthcare solutions company, have put together a few tips to help you proactively manage your exposure and response to allergens and allergy triggers – and help you get through allergy season more comfortably. Consider allergy testing. Consult your primary care provider (PCP)
Nordics Countries Seasonal Influenza Vaccine Market
Nordics Seasonal Influenza Vaccine Market Forecast in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination report published by Renub Research. According to this report, Sweden is having the highest seasonal influenza vaccine market share. In terms of children vaccination, Sweden & Denmark hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 60 percent market share by 2022. This
Seasonal Influenza Vaccination Market in Baltic Countries
Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast report published by Renub Research. According to this report, in the Baltic Countries, Lithuania is having the highest seasonal influenza vaccine market share followed by Latvia and Estonia. In terms of children vaccination, Lithuania & Latvia hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than
Job Search in New York: Seasonal Employment
For many people seasonal employment in New York is the first step towards the full-time employment in the chosen field. Seasonal job search in New York is available throughout the year, but most hiring take place in summer and winter when there is a busy holiday season and extra-help is needed. Seasonal jobs are the greatest opportunity to see the company inside operation and it is a good internship opportunity.